Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes. (Q35125149)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes. |
scientific article |
Statements
Targeting natural killer cell reactivity by employing antibody to NKp46: implications for type 1 diabetes (English)
Ofer Mandelboim
Chamutal Gur
Avishai Shemesh
Ofer Guttman
Uzi Hadad
Shlomo Nedvetzki
Antonija Miletić
Karen Nalbandyan
Adelheid Cerwenka
26 February 2015
26 February 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference